These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 33426464)

  • 1. IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405.
    Guercio BJ; Zhang S; Ou FS; Venook AP; Niedzwiecki D; Lenz HJ; Innocenti F; Pollak MN; Nixon AB; Mullen BC; O'Neil BH; Shaw JE; Polite BN; Benson AB; Atkins JN; Goldberg RM; Brown JC; O'Reilly EM; Mayer RJ; Blanke CD; Fuchs CS; Meyerhardt JA
    JNCI Cancer Spectr; 2021 Feb; 5(1):. PubMed ID: 33426464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.
    Kaaks R; Toniolo P; Akhmedkhanov A; Lukanova A; Biessy C; Dechaud H; Rinaldi S; Zeleniuch-Jacquotte A; Shore RE; Riboli E
    J Natl Cancer Inst; 2000 Oct; 92(19):1592-600. PubMed ID: 11018095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma insulin-like growth factors, insulin-like binding protein-3, and outcome in metastatic colorectal cancer: results from intergroup trial N9741.
    Fuchs CS; Goldberg RM; Sargent DJ; Meyerhardt JA; Wolpin BM; Green EM; Pitot HC; Pollak M
    Clin Cancer Res; 2008 Dec; 14(24):8263-9. PubMed ID: 19073970
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.
    Ma J; Pollak MN; Giovannucci E; Chan JM; Tao Y; Hennekens CH; Stampfer MJ
    J Natl Cancer Inst; 1999 Apr; 91(7):620-5. PubMed ID: 10203281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer.
    Wolpin BM; Meyerhardt JA; Chan AT; Ng K; Chan JA; Wu K; Pollak MN; Giovannucci EL; Fuchs CS
    J Clin Oncol; 2009 Jan; 27(2):176-85. PubMed ID: 19064975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective study of plasma C-peptide and colorectal cancer risk in men.
    Ma J; Giovannucci E; Pollak M; Leavitt A; Tao Y; Gaziano JM; Stampfer MJ
    J Natl Cancer Inst; 2004 Apr; 96(7):546-53. PubMed ID: 15069117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating levels of obesity-related markers and risk of renal cell carcinoma in the PLCO cancer screening trial.
    Liao LM; Hofmann JN; Cho E; Pollak MN; Chow WH; Purdue MP
    Cancer Causes Control; 2017 Jul; 28(7):801-807. PubMed ID: 28484923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical activity, insulin-like growth factor 1, insulin-like growth factor binding protein 3, and survival from colorectal cancer.
    Haydon AM; Macinnis RJ; English DR; Morris H; Giles GG
    Gut; 2006 May; 55(5):689-94. PubMed ID: 16299029
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
    Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The insulin-like growth factor family and breast cancer prognosis: A prospective cohort study among postmenopausal women in Denmark.
    Kalledsøe L; Dragsted LO; Hansen L; Kyrø C; Grønbæk H; Tjønneland A; Olsen A
    Growth Horm IGF Res; 2019 Feb; 44():33-42. PubMed ID: 30622040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma C-peptide, insulin-like growth factor-I, insulin-like growth factor binding proteins and risk of colorectal cancer in a nested case-control study: the Japan public health center-based prospective study.
    Otani T; Iwasaki M; Sasazuki S; Inoue M; Tsugane S;
    Int J Cancer; 2007 May; 120(9):2007-12. PubMed ID: 17266031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associations of insulin-like growth factor and insulin-like growth factor binding protein-3 with mortality in women with breast cancer.
    Duggan C; Wang CY; Neuhouser ML; Xiao L; Smith AW; Reding KW; Baumgartner RN; Baumgartner KB; Bernstein L; Ballard-Barbash R; McTiernan A
    Int J Cancer; 2013 Mar; 132(5):1191-200. PubMed ID: 22847383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance).
    Yuan C; Sato K; Hollis BW; Zhang S; Niedzwiecki D; Ou FS; Chang IW; O'Neil BH; Innocenti F; Lenz HJ; Blanke CD; Goldberg RM; Venook AP; Mayer RJ; Fuchs CS; Meyerhardt JA; Ng K
    Clin Cancer Res; 2019 Dec; 25(24):7497-7505. PubMed ID: 31548349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.
    Stattin P; Bylund A; Rinaldi S; Biessy C; Déchaud H; Stenman UH; Egevad L; Riboli E; Hallmans G; Kaaks R
    J Natl Cancer Inst; 2000 Dec; 92(23):1910-7. PubMed ID: 11106682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies.
    Rinaldi S; Cleveland R; Norat T; Biessy C; Rohrmann S; Linseisen J; Boeing H; Pischon T; Panico S; Agnoli C; Palli D; Tumino R; Vineis P; Peeters PH; van Gils CH; Bueno-de-Mesquita BH; Vrieling A; Allen NE; Roddam A; Bingham S; Khaw KT; Manjer J; Borgquist S; Dumeaux V; Torhild Gram I; Lund E; Trichopoulou A; Makrygiannis G; Benetou V; Molina E; Donate Suárez I; Barricarte Gurrea A; Gonzalez CA; Tormo MJ; Altzibar JM; Olsen A; Tjonneland A; Grønbaek H; Overvad K; Clavel-Chapelon F; Boutron-Ruault MC; Morois S; Slimani N; Boffetta P; Jenab M; Riboli E; Kaaks R
    Int J Cancer; 2010 Apr; 126(7):1702-15. PubMed ID: 19810099
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of animal and plant protein intakes with biomarkers of insulin and insulin-like growth factor axis.
    Lee DH; Tabung FK; Giovannucci EL
    Clin Nutr; 2022 Jun; 41(6):1272-1280. PubMed ID: 35504170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Milk intake, circulating levels of insulin-like growth factor-I, and risk of colorectal cancer in men.
    Ma J; Giovannucci E; Pollak M; Chan JM; Gaziano JM; Willett W; Stampfer MJ
    J Natl Cancer Inst; 2001 Sep; 93(17):1330-6. PubMed ID: 11535708
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediagnosis Circulating Insulin-Like Growth Factors and Pancreatic Cancer Survival.
    Toriola AT; Ziegler M; Li Y; Pollak M; Stolzenberg-Solomon R
    Ann Surg Oncol; 2017 Oct; 24(11):3212-3219. PubMed ID: 28681154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating insulin-like growth factor-I and binding protein-3 and the risk of breast cancer.
    Baglietto L; English DR; Hopper JL; Morris HA; Tilley WD; Giles GG
    Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):763-8. PubMed ID: 17416768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-3 levels and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort.
    Schairer C; McCarty CA; Isaacs C; Sue LY; Pollak MN; Berg CD; Ziegler RG
    Horm Cancer; 2010 Apr; 1(2):100-11. PubMed ID: 21761353
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.